Profile data is unavailable for this security.
About the company
Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is an international developer, manufacturer and distributor of effective rapid tests. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. The Abingdon Simply Test’s other selected self-test products, such as the saliva pregnancy test, Salistick, which is sold through international distributors and through other channels in the United Kingdom and Ireland, such as pharmacy chains.
- Revenue in GBP (TTM)8.43m
- Net income in GBP-3.42m
- Incorporated2008
- Employees121.00
- LocationAbingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
- Phone+44 19 0440 6050Fax+44 19 0446 2122
- Websitehttps://www.abingdonhealth.com/
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Genincode PLC | 2.91m | -4.97m |
| Surgical Innovations Group Plc | 11.92m | -1.44m |
| Cambridge Nutritional Sciences PLC | 8.06m | 1.37m |
| Feedback plc | 885.62k | -7.32m |
| Proteome Sciences plc | 4.53m | -3.33m |
| Rua Life Sciences PLC | 5.17m | -850.00k |
| Verici DX PLC | 1.41m | -5.60m |
| Genedrive PLC | 954.00k | -5.23m |
| Cellbxhealth PLC | 2.62m | -15.78m |
| Abingdon Health PLC | 8.43m | -3.42m |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m |
| Aptamer Group PLC | 1.20m | -2.42m |
| Renalytix PLC | 2.20m | -14.99m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Canaccord Genuity Wealth Ltd.as of 31 Oct 2025 | 43.70m | 17.41% |
| Octopus Investments Ltd.as of 07 Oct 2024 | 19.61m | 7.81% |
| Rathbones Investment Management Ltd.as of 07 Oct 2024 | 14.00m | 5.58% |
| Hargreaves Lansdown Asset Management Ltd.as of 07 Oct 2024 | 10.13m | 4.03% |
| Interactive Investor Services Ltd.as of 07 Oct 2024 | 7.18m | 2.86% |
| Unicorn Asset Management Ltd.as of 31 Dec 2025 | 1.93m | 0.77% |
| Oberon Investments Ltd. (GB Investment Management)as of 30 Jun 2025 | 250.98k | 0.10% |
